Related Articles
Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: Comparative study of immunohistochemistry and fluorescent in situ hybridization
Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder
Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization
Cyclooxygenase-2 expression in invasive transitional cell carcinoma of the urinary bladder
Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients